UCI-1
UCI-1 is a SARS-CoV-2 main protease (Mpro) cyclic peptide inhibitor with an IC50 of 160 μM. UCI-1 shows no obvious cytotoxicity at the concentration of inhibiting Mpro. UCI-1 can be used in the study of anti-COVID-19 drugs[1].
Product Specifications
UNSPSC
12352209
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(NCCC1=CC=C(CC2=O)C=C1)=O)=O)=O)[C@@H](N2)CC3=CC=CC=C3
Molecular Formula
C33H45N7O7
Molecular Weight
651.75
References & Citations
[1]Kreutzer AG, et al. A cyclic peptide inhibitor of the SARS-CoV-2 main protease. Eur J Med Chem. 2021 Oct 5;221:113530.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TBS10143-1MG 1 mg
Monoclonal Anti-human Luteinizing Hormone (hLH) Antibody
Sign In for Pricing
View Details